140 related articles for article (PubMed ID: 1397745)
21. Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis.
Cucchiara S; Minella R; Iervolino C; Franco MT; Campanozzi A; Franceschi M; D'Armiento F; Auricchio S
Arch Dis Child; 1993 Dec; 69(6):655-9. PubMed ID: 8285777
[TBL] [Abstract][Full Text] [Related]
22. [Different healing tendencies of reflux esophagitis following omeprazole and ranitidine. Results of a German-Austrian-Swiss multicenter study].
Dammann HG; Blum AL; Lux G; Rehner M; Riecken EO; Schiessel R; Wienbeck M; Witzel L; Berger J
Dtsch Med Wochenschr; 1986 Jan; 111(4):123-8. PubMed ID: 3510847
[TBL] [Abstract][Full Text] [Related]
23. Daily omeprazole surpasses intermittent dosing in preventing relapse of oesophagitis: a US multi-centre double-blind study.
Sontag SJ; Robinson M; Roufail W; Hirschowitz BI; Sabesin SM; Wu WC; Behar J; Peterson WL; Kranz KR; Tarnawski A; Dayal Y; Berman R; Simon TJ
Aliment Pharmacol Ther; 1997 Apr; 11(2):373-80. PubMed ID: 9146778
[TBL] [Abstract][Full Text] [Related]
24. High doses of ranitidine in patients with reflux oesophagitis.
Jansen JB; Lamers CB
Scand J Gastroenterol Suppl; 1990; 178():42-6. PubMed ID: 2277968
[TBL] [Abstract][Full Text] [Related]
25. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
[TBL] [Abstract][Full Text] [Related]
26. Medical therapy of patients with reflux oesophagitis poorly responsive to H2-receptor antagonist therapy.
Klinkenberg-Knol EC; Meuwissen SG
Digestion; 1992; 51 Suppl 1():44-8. PubMed ID: 1356868
[TBL] [Abstract][Full Text] [Related]
27. A comparison of five maintenance therapies for reflux esophagitis.
Vigneri S; Termini R; Leandro G; Badalamenti S; Pantalena M; Savarino V; Di Mario F; Battaglia G; Mela GS; Pilotto A
N Engl J Med; 1995 Oct; 333(17):1106-10. PubMed ID: 7565948
[TBL] [Abstract][Full Text] [Related]
28. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer.
Walan A; Bader JP; Classen M; Lamers CB; Piper DW; Rutgersson K; Eriksson S
N Engl J Med; 1989 Jan; 320(2):69-75. PubMed ID: 2643037
[TBL] [Abstract][Full Text] [Related]
29. Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis.
Vantrappen G; Rutgeerts L; Schurmans P; Coenegrachts JL
Dig Dis Sci; 1988 May; 33(5):523-9. PubMed ID: 3282846
[TBL] [Abstract][Full Text] [Related]
30. 24-hour intragastric acidity and plasma gastrin during long-term treatment with omeprazole or ranitidine in patients with reflux esophagitis.
Lind T; Cederberg C; Idström JP; Lönroth H; Olbe L; Lundell L
Scand J Gastroenterol; 1991 Jun; 26(6):620-6. PubMed ID: 1862300
[TBL] [Abstract][Full Text] [Related]
31. [Comparison of the cost-efficacy ratio of omeprazole and ranitidine in the treatment of reflux esophagitis].
Bergmann JF; Hamelin B; Barbier JP
Gastroenterol Clin Biol; 1995 May; 19(5):482-6. PubMed ID: 7589999
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials.
Carlsson R; Galmiche JP; Dent J; Lundell L; Frison L
Aliment Pharmacol Ther; 1997 Jun; 11(3):473-82. PubMed ID: 9218069
[TBL] [Abstract][Full Text] [Related]
33. Acute treatment of reflux oesophagitis: a multicentre study to compare 150 mg ranitidine twice daily with 300 mg ranitidine at bedtime.
Halvorsen L; Lee FI; Wesdorp IC; Johnson NJ; Mills JG; Wood JR
Aliment Pharmacol Ther; 1989 Apr; 3(2):171-81. PubMed ID: 2491468
[TBL] [Abstract][Full Text] [Related]
34. Omeprazole in the long-term treatment of gastro-oesophageal reflux disease. A double-blind randomized dose-finding study.
Laursen LS; Havelund T; Bondesen S; Hansen J; Sanchez G; Sebelin E; Fenger C; Lauritsen K
Scand J Gastroenterol; 1995 Sep; 30(9):839-46. PubMed ID: 8578181
[TBL] [Abstract][Full Text] [Related]
35. Ranitidine in reflux oesophagitis. A double-blind placebo-controlled study.
Hine KR; Holmes GK; Melikian V; Lucey M; Fairclough PD
Digestion; 1984; 29(2):119-23. PubMed ID: 6329862
[TBL] [Abstract][Full Text] [Related]
36. Comparison of omeprazole and histamine H2-receptor antagonists in the treatment of elderly and young patients with reflux oesophagitis.
James OF; Parry-Billings KS
Age Ageing; 1994 Mar; 23(2):121-6. PubMed ID: 8023719
[TBL] [Abstract][Full Text] [Related]
37. [Prognostic factors influencing healing of reflux esophagitis. A controlled trial of omeprazole versus ranitidine. Study group Omega].
Barbier JP; Haccoun P; Bergmann JF; Arnould B; Hamelin B
Ann Gastroenterol Hepatol (Paris); 1993; 29(4):213-8. PubMed ID: 8239492
[TBL] [Abstract][Full Text] [Related]
38. The effects of omeprazole and ranitidine on 24-hour pH in the distal oesophagus of patients with reflux oesophagitis.
Klinkenberg-Knol EC; Festen HP; Meuwissen SG
Aliment Pharmacol Ther; 1988 Jun; 2(3):221-7. PubMed ID: 2979246
[TBL] [Abstract][Full Text] [Related]
39. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of omeprazole in lower grades of gastro-oesophageal reflux disease.
Havelund T; Laursen LS; Lauritsen K
Scand J Gastroenterol Suppl; 1994; 201():69-73. PubMed ID: 8047827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
